General Pharmacodynamics Flashcards
when a substance is administered in a biological system, the effect is dependent on
concentration of the drug in the system or dose
The dose represents
amount of drug administered in that biological system
The representation of the intensity of the effect as a function of dose curve corresponds to
a certain mathematical relation according to which:
E = ( D X Emax ) / ( D + DE50 )
where E = the effect,
D = the dose (or concentration) of the substance,
Emax = the maximum effect that can be obtained in the respective biological system, and
DE50 represents = the dose that produces half (50%) of the maximum effect that can be obtained in that system
Evolution of the intensity of the effect of a drug on a biological system,
depending on
dose administered (dose / effect relationship)
endogenous
molecules with specific affinity for drugs are called
receptor molecules or
pharmacological receptors
Ka: affinity constant :
Ka = K1 / K2
Kd : dissociation constant :
Kd = K2 / K1
potency of a
drug is all the greater as
lower dose is required to achieve a certain intensity of effect.
In pharmacological practice the assessment of the potency of a drug is made taking into
account the
value of the dose that produces half of the maximum effect, a dose usually noted with DE50. The lower the DE50, the higher the potency of the drug
A certain substance, in order to produce a certain effect on a biological system,
must have two properties :
1) Affinity
2) Intrinsic activity
affinity
the ability of the substance to bind to
pharmacological receptors
intrinsic activity
the ability of the substance to activate
those receptors so as to produce a certain effect
agonists
Substances with affinity and intrinsic activity to certain pharmacological receptors are called agonists
antagonists.
Substance b has an affinity for the receptors but it has no intrinsic activity
Partial agonists
produce concentration-effect curves that resemble those observed with full agonists in the presence of an antagonist that irreversibly blocks some of the receptor sites
- Partial agonists have intrinsic activities greater than zero but less than one
Depending on their morphofunctional structure, 4 major types of pharmacological
receptors have been described :
- Ionic channels
- G protein coupled receptors
- The enzymatic receptors
- Nuclear receptors
Ionic channels
transmembrane structures consisting of 4 or 5 transmembrane subunits that surround a pore through which a particular species of ion can specifically
penetrate. Depending on the ion that can cross the ion channel, sodium channels,
potassium channels, calcium channels, chlorine channels, etc. have been described.
G protein-coupled receptors
- most widespread receptors in the
body - consist of 7 transmembrane segments
- joined together by 3 extracellular loops and 3 intracellular loops
- having a free extracellular
- initial portion and a free intracellular terminal portion
- The receptor drug binding site is located extracellularly and usually involves the transmembrane SIII segmen
- Sometimes, along with the SIII segment, the SIV or SV segment or even all three SIII, SIV and SV
segments is involved. - The third intracellular loop, which joins the SV and SVI
transmembrane segments, is coupled to a specific structure called the G protein.
3 types of G proteins were described, marked with Gs, Gi and Go. Gs and Gi
modify the function of
adenylate cyclase, the former stimulating its activity (s from stimulation), the latter inhibiting it (i from inhibition).
Go proteins stimulate
activity of phospholipase C and releases calcium from
intracellular deposits in the endoplasmic reticulum
The enzymatic receptors
- consist of a transmembrane portion,
- usually small in size,
- which joins an extracellular portion and an intracellular portion, which are relatively
large. - Sometimes these receptors are in dimeric form, as is the case with insulin receptors.
Nuclear receptors
- are intracellular structures consisting of 2 subunits: an effector subunit and a regulatory subunit with inhibitory role.
- The receptor-subunit effector subunit complex penetrates the nucleus and modifies the synthesis processes of enzymatic proteins